Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Conditions

Papillomavirus Infections 2Warts 1Uterine Cervical Dysplasia 1Infections 1High Grade Anal Canal Intraepithelial Neoplasia 1Condylomata Acuminata 1Cancer Survivor 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 30Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 20Papillomavirus Vaccines 9Radiotherapy, Intensity-Modulated 4Cisplatin 4Blood Specimen Collection 4fludarabine 3Vaccines, Synthetic 3Engerix-B 3Cyclophosphamide 3halofantrine 2fludarabine phosphate 2aldesleukin 2Watchful Waiting 2Vaccines 2Patient Navigation 2Paclitaxel 2Light Coagulation 2Interleukin-2 2Imiquimod 2Human Papillomavirus Recombinant Vaccine nonavalent 2Hepatitis A Vaccines 2Fluorouracil 2Electrocoagulation 2Cetuximab 2Carboplatin 2Albumin-Bound Paclitaxel 2utomilumab 1polyphenon E 1infigratinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Papillomavirus Infections × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT03036930 2026-05-29

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

National Cancer Institute (NCI)

Phase 2 Active not recruiting
51 enrolled 10 charts

Papillomavirus Infections

NCT01824537 2025-03-19

TRAP-HPV

McGill University

Phase 4 Completed
372 enrolled 12 charts

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡